Bis-choline tetrathiomolybdate
N/A
Report date: 2026/04/26 20:00:14
NME
Base Information
Drug NameBis-choline tetrathiomolybdate
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[22]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesWilson Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesMonopar Therapeutics IncWilson Therapeutics
Inactive CompaniesAttenuon LlcAlexion Pharmaceuticals Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A